SIREN : 440861979
LAURANE MEDICAL is a French company founded 24 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in SONCHAMP (78120), this company of category PME shows in 2022 a revenue of 28 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 28 222 € | 84 262 € | 78 488 € | 99 653 € | 933 105 € | 1 286 558 € | 1 171 412 € |
| Net income | -103 762 € | -22 663 € | -85 081 € | -106 220 € | 36 914 € | -22 249 € | 17 606 € |
| EBITDA | -108 673 € | -21 012 € | -91 604 € | -277 320 € | -131 490 € | -25 593 € | 29 628 € |
| Net margin | -367.7% | -26.9% | -108.4% | -106.6% | 4.0% | -1.7% | 1.5% |
In 2022, LAURANE MEDICAL achieves revenue of 28 k€. Revenue is declining over the period 2016-2022 (CAGR: -46.3%). Significant drop of -67% vs 2021. After deducting consumption (6 k€), gross margin stands at 22 k€, i.e. a rate of 78%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -109 k€, representing -385.1% of revenue. Warning negative scissor effect: despite revenue change (-67%), EBITDA varies by -417%, reducing margin by 360.1 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -104 k€ (-367.7% of revenue), which will impact equity.
28 222 €
22 093 €
-108 673 €
-117 851 €
-103 762 €
-385.1%
The debt ratio (= Financial debt / Equity x 100) stands at 1852%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 5%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
1851.656%
4.617%
-335.373%
-3.462
16.2%
In 2022, the debt ratio of LAURANE MEDICAL (1851.66) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
In 2022, the financial autonomy of LAURANE MEDICAL (4.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2022, the repayment capacity of LAURANE MEDICAL (-3.46) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 286.28. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
286.28
-0.045
In 2022, the liquidity ratio of LAURANE MEDICAL (286.28) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2022, the interest coverage of LAURANE MEDICAL (-0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 95 days. Excellent situation: suppliers finance 95 days of the operating cycle (retail model). Inventory turnover is 733 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 1086 days of revenue, i.e. 85 k€ to permanently finance. Notable WCR improvement over the period (-86%), freeing up cash.
85 140 €
0 j
95 j
733 j
1086 j
Based on 57 transactions of similar company sales
(all years),
the value of LAURANE MEDICAL is estimated at
6 400 €
(range 2 974€ - 13 392€).
The price/revenue ratio is 0.23x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare LAURANE MEDICAL with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire
The revenue of LAURANE MEDICAL in 2022 is 28 k€.
LAURANE MEDICAL recorded a net loss in 2022.
The headquarters of LAURANE MEDICAL is located in SONCHAMP (78120), in the department Yvelines.
The tax return of LAURANE MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
LAURANE MEDICAL operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.